Everence Capital Management Inc. Invests $555,000 in Avantor, Inc. (NYSE:AVTR)

Everence Capital Management Inc. purchased a new stake in shares of Avantor, Inc. (NYSE:AVTR) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 26,350 shares of the company’s stock, valued at approximately $555,000.

Other hedge funds have also bought and sold shares of the company. CIBC Asset Management Inc boosted its position in shares of Avantor by 6.4% in the 2nd quarter. CIBC Asset Management Inc now owns 22,875 shares of the company’s stock worth $485,000 after purchasing an additional 1,366 shares in the last quarter. Rhumbline Advisers grew its stake in shares of Avantor by 0.6% in the second quarter. Rhumbline Advisers now owns 785,294 shares of the company’s stock worth $16,648,000 after acquiring an additional 4,754 shares during the last quarter. TD Asset Management Inc increased its holdings in shares of Avantor by 3.1% during the second quarter. TD Asset Management Inc now owns 3,240,593 shares of the company’s stock valued at $68,701,000 after acquiring an additional 98,201 shares in the last quarter. Arizona State Retirement System increased its holdings in shares of Avantor by 0.3% during the second quarter. Arizona State Retirement System now owns 186,567 shares of the company’s stock valued at $3,955,000 after acquiring an additional 528 shares in the last quarter. Finally, North Star Asset Management Inc. boosted its stake in Avantor by 1.0% in the 2nd quarter. North Star Asset Management Inc. now owns 207,252 shares of the company’s stock worth $4,394,000 after purchasing an additional 2,078 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.

Analyst Ratings Changes

A number of research firms have weighed in on AVTR. Robert W. Baird reduced their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Royal Bank of Canada restated an “outperform” rating and issued a $34.00 price objective on shares of Avantor in a report on Thursday, September 26th. Wells Fargo & Company reduced their target price on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a report on Monday, October 28th. UBS Group lowered their price target on Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a report on Tuesday, October 8th. Finally, Barclays reduced their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Friday, October 25th. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $27.69.

Avantor Stock Up 2.6 %

Shares of AVTR stock opened at $21.76 on Friday. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. Avantor, Inc. has a 12 month low of $19.59 and a 12 month high of $28.00. The stock has a market cap of $14.81 billion, a P/E ratio of 47.30, a P/E/G ratio of 2.75 and a beta of 1.28. The company has a 50 day simple moving average of $21.57 and a two-hundred day simple moving average of $23.33.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.